Prosecution Insights
Prosecution Insights
91 pending office actions • 28 clients • 84 examiners • 47 art units • 0 of 91 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 45 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 45 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (3%) |
| §101 + other | 6 (7%) |
| §103 only | 27 (30%) |
| §102 only | 4 (4%) |
| §112 only | 5 (5%) |
| Double-patenting only | 3 (3%) |
| Double-patenting + other | 10 (11%) |
| Multi-statute (no §101) | 31 (34%) |
| No statute on record | 2 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORILLO, JANELL COMBS | 4 | 57.9% | +25.9% |
| NATARAJAN, MEERA | 2 | 62.3% | +17.6% |
| YOUTCHOM PENDIE, EMMANUEL LED | 2 | 55.6% | +50.0% |
| TURNER, FELICIA C | 2 | 26.3% | +30.3% |
| SAOUD, CHRISTINE J | 2 | 58.0% | +37.7% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.5% |
| COLEMAN, BRENDA LIBBY | 1 | 74.7% | +15.5% |
| BAUER, BRIANNA LEE | 1 | — | — |
| KIM, SEONG JONG | 1 | — | — |
| SHABMAN, MARK A | 1 | 84.2% | +13.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18178055 | PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS | FONTAINHAS, AURORA M | 153d overdue |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | SWIFT, CANDICE LEE | 91d overdue |
| 17776404 | LIBRARY OF BARCODED EXTRACELLULAR VESICLES | LAFAVE, ELIZABETH ROSE | 51d overdue |
| 17764104 | IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | PATTERSON, SARAH COOPER | 43d overdue |
| 18000322 | USE OF PRODUCTS MADE FROM ALUMINIUM COPPER MAGNESIUM ALLOY THAT PERFORM WELL AT HIGH TEMPERATURE | SHAMS, NAZMUN NAHAR | 31d overdue |
| 16994283 | USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION | HASAN, KHALEDA B | 30d overdue |
| 18156098 | THERMOMECHANICAL AGEING FOR 6XXX EXTRUSIONS | CARDA, DANIELLE MARIE | 26d overdue |
| 17771391 | PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES | MCANANY, JOHN D | 26d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17781682 | IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY | MORILLO, JANELL COMBS | 70d overdue |
| 16646495 | PROADRENOMEDULLIN AS INDICATOR FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS | SAOUD, CHRISTINE J | 20d |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | YOUTCHOM PENDIE, EMMANUEL LED | 34d |
| 15734102 | USE OF PEPTIDYLARGININE DEIMINASE TO OBTAIN IMPROVED FOOD | TURNER, FELICIA C | 36d |
| 18314878 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | YOUTCHOM PENDIE, EMMANUEL LED | 63d |
| 18301545 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | NATARAJAN, MEERA | 70d |
| 18511308 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | NATARAJAN, MEERA | 76d |
| 18940288 | GERANYLGERANYL PYROPHOSPHATE SYNTHASES | STEADMAN, DAVID J | — |
| Art Unit | Apps |
|---|---|
| 1793 | 6 |
| 1733 | 5 |
| 1791 | 4 |
| 1625 | 4 |
| 1651 | 3 |
| 1671 | 3 |
| 1643 | 3 |
| 1792 | 3 |
| 1738 | 3 |
| 1645 | 3 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18940288 | GERANYLGERANYL PYROPHOSPHATE SYNTHASES | DSM IP ASSETS B.V. | STEADMAN, DAVID J | §112DPOther | Non-Final OA | — | Pending | Nov 07, 2024 | |
| 18851859 | SYNTHESIS OF DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS | The United States Department of Health and Human Services | COLEMAN, BRENDA LIBBY | 1624 | §102 | Non-Final OA | — | Pending | Sep 27, 2024 |
| 18891013 | SULFONATED AND PHOSPHORYLATED AROMATIC MOLECULES | Xavier University Of Louisiana | BAUER, BRIANNA LEE | §103 | Non-Final OA | — | Pending | Sep 20, 2024 | |
| 18730668 | MOLIDUSTAT FORMULATIONS AND METHODS OF USE FOR TREATMENT OF ANEMIA IN CATS | Elanco Animal Health GmbH | KIM, SEONG JONG | §102§103§112 | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18753587 | DEVICE TO BE USED FOR CAPTURING EXTRACELLULAR VESICLES, AND PRESERVATION METHOD AND TRANSPORT METHOD FOR EXTRACELLULAR VESICLES | Craif Inc. | SHABMAN, MARK A | §102§103§112 | Non-Final OA | — | Pending | Jun 25, 2024 | |
| 18699970 | PROTEIN BAR | DSM IP ASSETS B.V. | SWEENEY, MAURA ELIZABETH | 1791 | §103 | Non-Final OA | 43d overdue | Pending | Apr 10, 2024 |
| 18698609 | NOVEL BINDER | DSM IP ASSETS B.V. | KERSHAW, KELLY P | 1791 | §102§103§112 | Non-Final OA | 70d | Pending | Apr 04, 2024 |
| 18691184 | HIGH-MOISTURE TEXTURIZED VEGETABLE PROTEIN | DSM IP ASSETS B.V. | LIU, DEBORAH YANG-HAO | 1791 | §103 | Final Rejection | 8d overdue | Pending | Mar 12, 2024 |
| 18691213 | PLANT BASED READY TO MIX COMPOSITION | DSM IP ASSETS B.V. | LEBLANC, KATHERINE DEGUIRE | 1791 | §103§112 | Non-Final OA | 46d | Pending | Mar 12, 2024 |
| 18690087 | NEW QUINOLINE DERIVATIVES | Elanco Animal Health GmbH | SHTERENGARTS, SAMANTHA L | 1623 | DP | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18594869 | CRISPR TRANSIENT EXPRESSION CONSTRUCT (CTEC) | DSM IP ASSETS B.V. | REGA, KYLE THOMAS | 1636 | §103 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18588777 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | MONSHIPOURI, MARYAM | 1651 | §112 | Final Rejection | — | Pending | Feb 27, 2024 |
| 18580849 | PEA AND RAPESEED PROTEIN ISOLATE | DSM IP ASSETS B.V. | MCCLAIN, TYNESHA L. | 1793 | §103 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18579769 | METHOD OF TREATING DRUG RESISTANT ESKAPEE PATHOGENS USING THERAPEUTIC BACTERIOPHAGES | The United States Government (Department of the Army) | GILL, RACHEL B | 1671 | §102§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18576593 | PROCESS FOR MAKING DIARYL ISOXAZOLINE DERIVATIVE | Elanco US Inc. | BARBER, KIMBERLY | 1615 | §112DP | Final Rejection | — | Pending | Jan 04, 2024 |
| 18538605 | FORMULATIONS FOR TREATING ACID REFLUX COMPRISING SODIUM ALGINATE | Pharagen LLC | COHEN, MICHAEL P | 1612 | §103 | Non-Final OA | 13d | Pending | Dec 13, 2023 |
| 18569414 | CRYSTALLINE FORMS OF ISOXAZOLINE COMPOUND | Elanco US, Inc. | ENGLISH, CONNOR KENNEDY | 1625 | §103§112 | Final Rejection | 16d overdue | Pending | Dec 12, 2023 |
| 18569370 | (THI)OXAZOLINE PESTICIDES | BAYER AKTIENGESELLSCHAFT | WEDDINGTON, KEVIN E | 1629 | §102 | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18569408 | ISOXAZOLINE PESTICIDES | BAYER AKTIENGESELLSCHAFT | VALLE, ERNESTO | 1623 | §112DP | Non-Final OA | — | Pending | Dec 12, 2023 |
| 18533733 | PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NON-SMALL CELL LUNG CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | SANG, HONG | §102§103§112DP | Non-Final OA | — | Pending | Dec 08, 2023 | |
| 18567588 | ALUMINUM ALLOY PLATE SHEET FOR PARALLELEPIPED BATTERY HOUSING | Constellium Rolled Products Singen GmbH & Co.Kg | ROE, JESSEE RANDALL | 1759 | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2023 |
| 18529686 | FUNCTIONALIZED CALIBRANTS FOR SPECTROMETRY AND CHROMATOGRAPHY | Polymer Factory Sweden AB | XU, XIAOYUN | 1797 | §103 | Final Rejection | — | Pending | Dec 05, 2023 |
| 18527530 | FERMENTATIVELY-PRODUCED RETINOID CONTAINING COMPOSITIONS, AND THE METHDOS OF MAKING AND USING THE SAME | DSM IP ASSETS B.V. | WELLS, LAUREN QUINLAN | 1622 | §103 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18561758 | A 6XXX ALLOY FOR HIGH STRENGTH EXTRUDED PRODUCTS WITH HIGH PROCESSABILITY | CONSTELLIUM EXTRUSIONS LEVICE S.R.O. | MORILLO, JANELL COMBS | 1733 | §102§103 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18511308 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | Immatics Biotechnologies GmbH | NATARAJAN, MEERA | 1643 | §112 | Non-Final OA | 76d | Pending | Nov 16, 2023 |
| 18560853 | FISH FLAVOUR AND FISH ANALOGUE PRODUCT | DSM IP ASSETS B.V. | LACHICA, ERICSON M | 1792 | §103§112 | Non-Final OA | 34d | Pending | Nov 14, 2023 |
| 18505361 | METHODS OF IDENTIFYING METASTATIC LESIONS IN A PATIENT AND TREATING THEREOF | Immatics Biotechnologies GmbH | REDDIG, PETER J | 1646 | §103DP | Non-Final OA | — | Pending | Nov 09, 2023 |
| 18558040 | 5XXX ALUMINIUM SHEETS FOR CAN MAKING | Constellium Rolled Products Singen GmbH & Co. Kg | CHRISTY, KATHERINE A | 1784 | §103§112 | Non-Final OA | 4d overdue | Pending | Oct 30, 2023 |
| 18553817 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | FRONDA, CHRISTIAN L | 1652 | DP | Final Rejection | — | Pending | Oct 03, 2023 |
| 18553801 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | SAIDHA, TEKCHAND | 1652 | §102§112 | Final Rejection | — | Pending | Oct 03, 2023 |
| 18472942 | MIRNAS, COMPOSITIONS, AND METHODS OF USING THEREOF | Craif Inc. | DAUNER, JOSEPH G | 1699 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18551614 | PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM | BAYER AKTIENGESELLSCHAFT | OH, TAYLOR V | 1625 | §103§112 | Non-Final OA | 13d | Pending | Sep 21, 2023 |
| 18551454 | DIAGNOSIS OF ALZHEIMER'S DISEASE BY DETECTING AUTO-ANTIBODIES AGAINST Y-BOX BINDING PROTEIN-1 (YB-1) | Celltrend GmbH | COUNTS, GARY W | 1678 | §101 | Final Rejection | 5d | Pending | Sep 20, 2023 |
| 18548983 | FROZEN FOOD PRODUCT, NATURAL STABILIZER, FROZEN FOOD PRODUCTION METHOD AND THE SIEVE SYSTEM | Krzysztof Ciuhak | BEKKER, KELLY JO | 1792 | §102§103§112 | Final Rejection | 9d overdue | Pending | Sep 05, 2023 |
| 18547037 | FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE | The United States Department of Health and Human Services | JOHNSON, KARA D | 1632 | §102§103 | Non-Final OA | — | Pending | Aug 18, 2023 |
| 18451216 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | NICKOL, GARY B | 1643 | §112DPOther | Non-Final OA | 69d | Pending | Aug 17, 2023 |
| 18546604 | COATED MEAT OR FISH SUBSTITUTE | DSM IP ASSETS B.V. | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Non-Final OA | 112d overdue | Pending | Aug 16, 2023 |
| 18448998 | THICK PLATES MADE OF AL-CU-LI ALLOY WITH IMPROVED FATIGUE PROPERTIES | Constellium Issoire | WALCK, BRIAN D | 1738 | §103§112 | Non-Final OA | — | Pending | Aug 14, 2023 |
| 18366306 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES | Elanco Animal Health GmbH | RAHMAN, MASUDUR | 1633 | §103§112 | Non-Final OA | 34d | Pending | Aug 07, 2023 |
| 18361018 | METHOD FOR REDUCING SURFACE TENSION OF POLYMER MATERIAL AND METHOD FOR CONTROLLING ORIENTATION OF BLOCK COPOLYMER THIN FILM BY DECOMPRESSION EFFECT | National Tsing Hua University | BHUSHAN, KUMAR R | 1766 | §102 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 18262949 | VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE | BAYER AKTIENGESELLSCHAFT | MORGAN, BAILEY MICHELLE | 1645 | DP | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18345700 | PEPTIDES, COMBINATION OF PEPTIDES, AND CELL BASED MEDICAMENTS FOR USE IN IMMUNOTHERAPY AGAINST URINARY BLADDER CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | CANELLA, KAREN A | §112 | Non-Final OA | — | Pending | Jun 30, 2023 | |
| 18343502 | TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS | Immatics Biotechnologies GmbH | SKELDING, ZACHARY S | 1644 | §112Other | Non-Final OA | — | Pending | Jun 28, 2023 |
| 18258071 | TNF ALPHA AND NGF ANTIBODIES FOR VETERINARY USE | Elanco US, Inc. | STONEBRAKER, ALYSSA RAE | 1642 | §103 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18324203 | MANUFACTURING PROCESS FOR OBTAINING HIGH STRENGTH EXTRUDED PRODUCTS MADE FROM 6XXX ALUMINIUM ALLOYS | CONSTELLIUM SINGEN GMBH | MORILLO, JANELL COMBS | 1733 | §103§112 | Final Rejection | — | Pending | May 26, 2023 |
| 18323577 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS | Immatics Biotechnologies GmbH | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | Other | Non-Final OA | 34d | Pending | May 25, 2023 |
| 18253061 | N-(2,3-DIHYDRO-1,4-BENZOXAZIN-4-YL)-3-ISOPROPYL-7-(2,3,5-TRIFLUOROPHENYL)BENZO-THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND SIMILAR COMPOUNDS FOR THE TREATMENT OF HEARTWORM INFECTIONS | Elanco Tiergesundheit AG | LEE, CHIHYI NMN | 1628 | §102§103§112DP | Final Rejection | 60d overdue | Pending | May 16, 2023 |
| 18314878 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC, SCLC AND OTHER CANCERS | Immatics Biotechnologies GmbH | YOUTCHOM PENDIE, EMMANUEL LED | 1647 | §103 | Non-Final OA | 63d | Pending | May 10, 2023 |
| 18315183 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS | Immatics Biotechnologies GmbH | MOSELEY II, NELSON B | 1642 | Other | Non-Final OA | 27d | Pending | May 10, 2023 |
| 18309062 | DOMINANT NEGATIVE TGFBETA RECEPTOR POLYPEPTIDES, CD8 POLYPEPTIDES, CELLS, COMPOSITIONS, AND METHODS OF USING THEREOF | Immatics US, Inc. | GROOMS, TIFFANY NICOLE | 1637 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18301545 | ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME | Immatics Biotechnologies GmbH | NATARAJAN, MEERA | 1643 | §112DPOther | Final Rejection | 70d | Pending | Apr 17, 2023 |
| 18300750 | SILICONE FOAM WHICH IS AIR FOAMED AND SYNTACTIC AND ARTICLE SUCH AS A SECONDARY BATTERY PACK COMPRISING SAID FOAM | Elkem Silicones Usa Corp. | KRYLOVA, IRINA | 1764 | §103§112 | Final Rejection | — | Pending | Apr 14, 2023 |
| 17641054 | BODY FLUID EXTRACT CONTAINING MICRO RNA | Craif Inc. | HOPPE, EMMA RUTH | 1683 | §101§112 | Non-Final OA | 70d | Pending | Apr 14, 2023 |
| 18297069 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS | Immatics Biotechnologies GmbH | MELCHIOR, JAMES RYLAND | 1644 | §103Other | Non-Final OA | 60d overdue | Pending | Apr 07, 2023 |
| 18028390 | HEAT SHRINKABLE FILMS, AND METHOD OF MANUFACTURING THE SAME | Klöckner Pentaplast Of America, Inc. | CHEN, VIVIAN | 1787 | §103§112 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 18025118 | FLUID RETAINING SUBSTRATE | Linpac Packaging Limited | COLLINS, RAVEN | 3735 | §102§103 | Final Rejection | — | Pending | Mar 07, 2023 |
| 18178055 | PERSONALIZED IMMUNOTHERAPY AGAINST SEVERAL NEURONAL AND BRAIN TUMORS | Immatics Biotechnologies GmbH | FONTAINHAS, AURORA M | 1675 | §101Other | Non-Final OA | 153d overdue | Pending | Mar 03, 2023 |
| 18041362 | MONITORING AND CONTROLLING BACTERIOPHAGE PRESSURE | DSM IP ASSETS B.V. | CLOW, LORI A | §101§103§112 | Non-Final OA | — | Pending | Feb 10, 2023 | |
| 18006361 | SYSTEM AND METHODS FOR DETECTION OF PATHOGENIC VIRUSES | Viroforge Technologies, LLC | STUART, CAREY ALEXANDER MC | 1671 | §103§112DP | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18156098 | THERMOMECHANICAL AGEING FOR 6XXX EXTRUSIONS | CONSTELLIUM SINGEN GMBH | CARDA, DANIELLE MARIE | 1738 | §103§112 | Non-Final OA | 26d overdue | Pending | Jan 18, 2023 |
| 18000322 | USE OF PRODUCTS MADE FROM ALUMINIUM COPPER MAGNESIUM ALLOY THAT PERFORM WELL AT HIGH TEMPERATURE | Constellium Issoire | SHAMS, NAZMUN NAHAR | 1738 | §103§112 | Non-Final OA | 31d overdue | Pending | Nov 30, 2022 |
| 17996549 | IL4/IL13 RECEPTOR MOLECULES FOR VETERINARY USE | Elanco US Inc. | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103§112Other | Non-Final OA | 19d overdue | Pending | Oct 19, 2022 |
| 17995968 | METHOD FOR PRODUCING AN ALUMINIUM ALLOY PART | C-Tec Constellium Technology Center | HILL, STEPHANI A | 1735 | §103Other | Final Rejection | 15d | Pending | Oct 11, 2022 |
| 17906826 | THE COMBINED USE OF PHYTASE AND PAD TO OBTAIN AN IMPROVED PLANT-BASED DRINK | DSM IP ASSETS B.V. | TURNER, FELICIA C | 1793 | §103 | Final Rejection | — | Pending | Sep 20, 2022 |
| 17906112 | ACCELERATING THE ACIDIFICATION SPEED OF LACTIC ACID BACTERIA | DSM IP ASSETS B.V. | MUKHOPADHYAY, BHASKAR | 1792 | §103§112 | Final Rejection | — | Pending | Sep 12, 2022 |
| 17908194 | SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALS | Elanco Animal Health GmbH | SHIN, MONICA A | 1616 | §103§112 | Non-Final OA | 18d overdue | Pending | Aug 30, 2022 |
| 17795652 | PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON NON-HUMAN ORGANISMS | Elanco Animal Health GmbH | HUTTER, GILLIAN A | 1625 | §103§112 | Final Rejection | — | Pending | Jul 27, 2022 |
| 17842842 | PROCESS FOR PRODUCING OLIVE OIL | DSM IP ASSETS B.V. | HAWKINS, AMANDA SALATA | 1793 | §103 | Final Rejection | 34d | Pending | Jun 17, 2022 |
| 17781682 | IMPROVED METHOD FOR MANUFACTURING A STRUCTURE COMPONENT FOR A MOTOR VEHICLE BODY | Constellium Neuf-Brisach | MORILLO, JANELL COMBS | 1733 | §103 | Final Rejection | 70d overdue | Pending | Jun 01, 2022 |
| 17828744 | THERMOFORMABLE FILM FOR BARRIER PACKAGING AND METHODS OF FORMING THE SAME | Klöckner Pentaplast Of America, Inc. | SHUKLA, KRUPA | 1787 | §103 | Final Rejection | — | Pending | May 31, 2022 |
| 17776404 | LIBRARY OF BARCODED EXTRACELLULAR VESICLES | The University of Tokyo | LAFAVE, ELIZABETH ROSE | 1684 | §101§103 | Non-Final OA | 51d overdue | Pending | May 12, 2022 |
| 17771732 | NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES | BAYER AKTIENGESELLSCHAFT | RODRIGUEZ-GARCIA, VALERIE | 1621 | §112 | Non-Final OA | — | Pending | Apr 25, 2022 |
| 17771391 | PROTEIN KINASE INHIBITORS AND USE THEREOF FOR TREATMENT OF NEURODEGENERATIVE DISEASES | Xavier University Of Louisiana | MCANANY, JOHN D | 1625 | §102§103 | Final Rejection | 26d overdue | Pending | Apr 22, 2022 |
| 17764104 | IMMUNOGENIC EGFR PEPTIDE COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CANCER | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | PATTERSON, SARAH COOPER | 1675 | §103§112 | Final Rejection | 43d overdue | Pending | Mar 25, 2022 |
| 17762325 | TREATMENT AND PREVENTION OF AGING RELATED-DISEASE AND/OR AGING BY THE INHIBITION OF SPHINGOLIPIDS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | RAHMANI, NILOOFAR | 1691 | §102 | Final Rejection | 7d | Pending | Mar 21, 2022 |
| 17640262 | ENZYME COMPOSITION | DSM IP ASSETS B.V. | REGLAS, GEORGIANA C | 1651 | §103 | Final Rejection | 1d overdue | Pending | Mar 03, 2022 |
| 17603789 | PHAGE TEST KIT | DSM IP ASSETS B.V. | ZOU, NIANXIANG | 1671 | §103 | Final Rejection | 30d overdue | Pending | Oct 14, 2021 |
| 17434262 | MACROCYCLIC LACTONE ANTHELMINTICS AGAINST NEMATODES | BAYER AKTIENGESELLSCHAFT | BAEK, BONG-SOOK | 1611 | §103 | Final Rejection | — | Pending | Aug 26, 2021 |
| 17431997 | NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR | Merz Pharma GmbH & Co. Kgaa | GOUGH, TIFFANY MAUREEN | 1651 | §103DP | Final Rejection | 44d overdue | Pending | Aug 18, 2021 |
| 17424671 | METHOD FOR MANUFACTURING A PART FROM ALUMINIUM ALLOY, THE ALLOY COMPRISING AT LEAST ZIRCONIUM AND MAGNESIUM | C-Tec Constellium Technology Center | SMITH, CATHERINE P | 1735 | §103 | Final Rejection | — | Pending | Jul 21, 2021 |
| 17051659 | ALUMINUM-COPPER-LITHIUM ALLOY HAVING IMPROVED COMPRESSIVE STRENGTH AND IMPROVED TOUGHNESS | Constellium Issoire | MORILLO, JANELL COMBS | 1733 | §103 | Final Rejection | — | Pending | Jun 22, 2021 |
| 17258670 | HEALTHCARE MANAGEMENT METHOD | Provigate Inc. | HRANEK, KAREN AMANDA | 3684 | §101 | Final Rejection | 9d | Pending | Jun 16, 2021 |
| 17414839 | PHAGE RESISTANT LACTIC ACID BACTERIA | DSM IP ASSETS B.V. | SWIFT, CANDICE LEE | 1657 | §102§103§112Other | Final Rejection | 91d overdue | Pending | Jun 16, 2021 |
| 17327271 | METHODS FOR DETECTING proADM IN A CRITICALLY ILL SUBJECT WHO HAS BEEN ADMITTED TO AN INTENSIVE CARE UNIT | B.R.A.H.M.S GmbH | SAOUD, CHRISTINE J | 1645 | §101§112DP | Final Rejection | — | Pending | May 21, 2021 |
| 17284875 | Fc Variants with Altered Binding to Neonatal Fc Receptor (FCRN) for Veterinary Use | Elanco US Inc. | NGUYEN, NAM P | 1678 | §103§112 | Final Rejection | — | Pending | Apr 13, 2021 |
| 17282326 | PROCESS FOR MANUFACTURING AN ALUMINUM ALLOY PART | C-Tec Constellium Technology Center | LUK, VANESSA TIBAY | 1733 | §103 | Final Rejection | 42d overdue | Pending | Apr 01, 2021 |
| 17255852 | FATTY ACID-GRAFTED HYALURONIC ACID, DERMAL FILLER FORMULATIONS COMPRISING SAME, PROCESS FOR PREPARATION AND USE THEREOF | Merz Pharma GmbH & Co. Kgaa | MATTISON, LORI K | 1619 | §103 | Final Rejection | 2d overdue | Pending | Dec 23, 2020 |
| 15734727 | MODIFIED RAPESEED PROTEIN ISOLATE | DSM IP ASSETS B.V. | TRAN, LIEN THUY | 1793 | §103 | Final Rejection | 45d overdue | Pending | Dec 03, 2020 |
| 15734102 | USE OF PEPTIDYLARGININE DEIMINASE TO OBTAIN IMPROVED FOOD | DSM IP ASSETS B.V. | TURNER, FELICIA C | 1793 | §103 | Non-Final OA | 36d | Pending | Dec 01, 2020 |
| 16994283 | USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION | The Provost, Fillows, Foundatio Scholars, & The Other Members Of Board, Of The College Of The Holy | HASAN, KHALEDA B | 1636 | §102§112 | Non-Final OA | 30d overdue | Pending | Aug 14, 2020 |
| 16646495 | PROADRENOMEDULLIN AS INDICATOR FOR RENAL REPLACEMENT THERAPY IN CRITICALLY ILL PATIENTS | B.R.A.H.M.S GmbH | SAOUD, CHRISTINE J | 1645 | §103 | Final Rejection | 20d | Pending | Mar 11, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial